首页>
外国专利>
MEDICINAL PRODUCTS FOR THE PREVENTION OR TREATMENT OF EQUIPMENT INCLUDING HIGHER INTRAOKULAR NEOVACULARISATION AND/ OR INTRAOKULAR PHASE PERFORMANCE
MEDICINAL PRODUCTS FOR THE PREVENTION OR TREATMENT OF EQUIPMENT INCLUDING HIGHER INTRAOKULAR NEOVACULARISATION AND/ OR INTRAOKULAR PHASE PERFORMANCE
展开▼
机译:用于预防或治疗设备的药品,包括高血肿瘤内透析和/或内部阶段性能
展开▼
页面导航
摘要
著录项
相似文献
摘要
Provided is a pharmaceutical for preventing or treating an ophthalmic disease associated with intraocular neovascularization and/or increased intraocular vascular permeability. The inventors of the present invention have made investigations on a pharmaceutical for preventing or treating an ophthalmic disease associated with intraocular neovascularization and/or increased intraocular vascular permeability, and have confirmed that a selective S1P receptor agonist having agonist activity at an S1P1 receptor has an intraocular neovascularization-reducing action and an intraocular vascular permeability-reducing action, thus completing the present invention. A compound or a pharmaceutically acceptable salt thereof of the present invention, which serves as the selective S1P receptor agonist having agonist activity at the S1P1 receptor, has an intraocular neovascularization-reducing action and an intraocular vascular permeability-reducing action, and can be used as a preventive and/or therapeutic agent for, for example, exudative age-related macular degeneration, diabetic retinopathy, diabetic macular edema, myopic choroidal neovascularization, retinal artery occlusion, retinal vein occlusion, or neovascular glaucoma.
展开▼